When we think about metabolic health, we usually think about body weight.
More specifically, we think about BMI.
But what if BMI is missing the most important part of the story?
In this week’s Metabolic Classroom, we explore one of the most misunderstood — and underappreciated — topics in metabolic health: the relationship between ethnicity, body fat distribution, and why the size and behavior of your fat cells matter far more than the number on the scale.
Prefer to listen without the ads? Become a Ben Bikman Insider.
The Diabetes Paradox
Consider this:
The United States has one of the highest obesity rates in the world — roughly 40% of adults qualify as obese by standard BMI criteria.
Singapore, on the other hand, has far lower obesity rates.
Yet both countries have nearly identical rates of type 2 diabetes — around 10–11% of adults.
How is that possible?
If obesity causes diabetes, shouldn’t higher obesity always mean higher diabetes?
This paradox tells us something profound:
It’s not just how much fat someone carries. It’s how and where that fat is stored.
Fat Cells: Hypertrophy vs. Hyperplasia
Fat tissue isn’t just passive storage. It’s metabolically active. And it can expand in two fundamentally different ways:
1. Hypertrophy — Fat Cells Get Bigger
This is when existing fat cells swell and enlarge.
Large fat cells become:
- Insulin resistant
- Pro-inflammatory
- More likely to release excess free fatty acids
- More likely to drive fat accumulation in the liver
Hypertrophic fat tissue is strongly linked to insulin resistance, fatty liver, and type 2 diabetes.
2. Hyperplasia — More Small Fat Cells
This is when the body creates new, small fat cells to store excess energy.
Small fat cells:
- Remain insulin sensitive
- Store fat safely
- Maintain normal hormone signaling
- Are less inflammatory
Two individuals can carry the same total fat mass — but the one storing fat in many small cells may be metabolically healthy, while the one storing fat in fewer large cells may be on the path toward disease.
It’s not total fat mass that determines risk. It’s fat cell size and function.
When Fat Storage Fails
Under healthy conditions, insulin suppresses fat breakdown (lipolysis). High insulin means fat stays stored.
But when fat cells become hypertrophic and insulin resistant, this control breaks down.
Now you have:
- High insulin
- High circulating free fatty acids
- Fat being pushed into the liver
- Rising liver fat and worsening insulin resistance
This is the beginning of metabolic syndrome.
As fat cells enlarge further, they become poorly oxygenated. This hypoxia activates inflammatory pathways, recruits immune cells, and drives chronic systemic inflammation.
Metabolic dysfunction spreads beyond fat tissue — affecting the liver, muscle, and pancreas.
The Adipose Expandability Hypothesis
Researchers have proposed a powerful framework called the adipose expandability hypothesis.
The idea is simple:
The body has a limited capacity to safely store fat in subcutaneous tissue (fat under the skin).
When that capacity is exceeded:
- Fat spills into visceral depots (around organs)
- Fat accumulates in the liver and muscle
- Metabolic dysfunction accelerates
The key question becomes:
How much safe storage capacity does someone have?
And this is where ethnicity becomes critically important.
Ethnicity and Fat Storage Capacity
Different populations have different tendencies in fat distribution.
South Asians
Individuals of Indian, Pakistani, Bangladeshi, and Sri Lankan descent often display what researchers call the “thin-fat phenotype.”
At the same BMI, South Asians tend to have:
- Higher body fat percentage
- More abdominal and visceral fat
- Less protective subcutaneous fat
- Higher liver fat
This means metabolic risk begins at lower BMIs.
A BMI of 24 in a South Asian individual may carry a diabetes risk equivalent to a BMI of 30 in someone of European ancestry.
East Asians
Chinese, Japanese, and Korean populations also tend to accumulate visceral fat at lower BMIs compared to Europeans.
African Ancestry Populations
Interestingly, individuals of African ancestry often show greater peripheral subcutaneous fat storage relative to visceral fat at comparable BMIs — which may partially influence differences in metabolic risk patterns.
These are general trends, not absolutes — but the pattern is consistent across large population studies.
The BMI Problem
Standard BMI cutoffs were developed largely from European population data.
But research now shows that these cutoffs do not translate equally across ethnic groups.
For equivalent diabetes risk:
- South Asian BMI thresholds are significantly lower
- East Asian thresholds are lower
- European thresholds are higher
This means millions of individuals may be labeled “normal weight” while already metabolically compromised.
BMI tells you nothing about:
- Fat cell size
- Visceral fat
- Liver fat
- Insulin resistance
- Inflammation
It only measures weight relative to height.
And metabolic health is far more complex than that.
A Better Framework for Thinking About Fat
Fat itself is not the enemy.
The body is designed to store excess energy safely.
Problems arise when:
- Fat cells enlarge beyond healthy capacity
- Insulin control over fat breakdown fails
- Inflammation develops
- Fat accumulates in the liver and organs
And because the threshold for this breakdown varies by ethnicity, BMI alone cannot define metabolic risk.
The real questions are:
- Where is the fat stored?
- Are the fat cells small and functional — or large and inflamed?
- Is the liver accumulating fat?
- Is insulin functioning properly?
The Takeaway
Two people can weigh the same.
Have the same BMI.
Appear equally lean.
Yet one may be metabolically healthy — and the other already insulin resistant.
The difference lies in fat distribution, fat cell size, and the body’s capacity for safe storage.
Understanding this changes how we assess risk, how we counsel patients, and how we interpret metabolic health across diverse populations.
BMI is a crude tool.
Adipocyte biology tells the real story.